This Promising GLP-1 Drug Could Renew Novo Nordisk Hope
Novo Nordisk has faced headwinds, but a new GLP-1 drug could change the game. This article breaks down what investors...
Explore how volatility affects retirees in index funds and what tactics—like rebalancing and withdrawal rules—can help manage risk.
23,516 articlesNovo Nordisk has faced headwinds, but a new GLP-1 drug could change the game. This article breaks down what investors...
Affirm stock has caught investors' attention as it swings between growth bets and risk concerns. This guide breaks do...
A late-stage private AI company is inviting retail buyers to participate in a sub-$1 pre-IPO round, with shares at $0...
A federal judge pressed the government over its bid to block Anthropic’s AI from top-secret systems. The hearing unde...
An anonymous investor continues to buy the VanEck Uranium and Nuclear ETF every month, betting on nuclear power's lon...
As InMode lays out its 2026 plan, investors want clarity on growth engines, margins, and execution. This article brea...
Remax Holdings posted a revenue decline and a sharper net loss in Q1 2026, while debt rose to $436 million. Real Brok...
Visa and Mastercard lead the global payments world, forming a true duopoly. This article breaks down which stock off...
New on-chain data shows a growing cohort of XRP whales, with wallets holding 10,000 XRP or more rising to a new high....
Ondas (ONDS) reports its Q1 2026 results, revealing early signs of progress and persistent headwinds. This guide brea...
Bitcoin remains stuck below its long-running 200-day moving average, trading near $58,000 as of mid‑May 2026. A decis...
Senator Elizabeth Warren escalates her opposition to the OCCs handling of crypto trust charters, arguing the agency h...